Clinical significance of circulating soluble CD163 in patients with liver cirrhosis

Na Li,Xiaoqing Zeng,Duyi Pan,Yimei Liu,Qing Miao,Guifen Ma,Shiyao Chen

DOI: https://doi.org/10.3877/cma.j.issn.1674-0785.2015.09.011

2015-01-01

Abstract:Objective To investigate the level of circulating soluble CD163 (sCD163) in liver cirrhosis, and to explore its diagnostic value as a noninvasive method. Methods The levels of sCD163 were quantitatively detected in 41 patients with liver cirrhosis and 20 health controls by ELISA, diagnostic value was analyzed by receive operating characteristic (ROC) curve, and its correlation with clinical pathological characters was also compared. Results The levels of serum sCD163 expression were significantly higher than those in healthy controls [(92.53±3.34)μg/L vs.(58.22±3.12)μg/L, P<0.001], and increased along with Child-Pugh classification [(76.99±4.46)μg/L vs.(99.69±4.04)μg/L vs.(112.90±3.59)μg/L, all P<0.05]. The expression of sCD163 closely related with complications like ascites and spontaneous bacterial peritonitis (SBP). Ascitic patients showed higher concentration of sCD163 than those without ascites [(100.70±3.36)μg/L vs.(78.39±5.43)μg/L, P<0.01], and correlated with the severity of ascites. Patients with SBP also exhibited higher circulating sCD163 level [(120.4±1.41)μg/L vs.(88.66±3.31)μg/L, P<0.01]. The area under ROC curve of sCD163 expression were 0.901. Taken 80.12μg/L as a critical point for sCD163, specificity predicting the diagnosis of liver cirrhosis was 95%. Also sCD163>80.12μg/L predicted the development of ascites with a sensitivity of 73.1%and specificity of 80%. Conclusion sCD163, as a marker of macrophage activation, increased significantly in patients with liver cirrhosis, which indicated that the levels of serum sCD163 expression could be a useful molecular marker for noninvasive diagnosis of liver cirrhosis. Furthermore, serum sCD163 level also associated with complications like ascites and SBP, which manifested that it may be involved in the progression of liver cirrhosis and can work as a method of monitoring the clinical disease course.